September 2018 FDA Recall Drug by Par Pharmaceutical, Inc.
D-1185-2018 - Failed impurities/degradation specifications

This Class III drug recall was voluntarily initiated by Par Pharmaceutical, Inc. on September 6, 2018 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1185-2018

Reason for Recall
Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.
Initiated
09-06-2018
Reported
09-19-2018
Quantity
16,207 (bottles of 30 tablets)

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Par Pharmaceutical, Inc.
United States nationwide
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

Batch or Lot Expiration Information

Lot# : 29906202, Exp 12/18; 29993102, Exp 2/19; 30366102, 30373103, Exp 4/19; 31940601, Exp 3/20.